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Abstract 
The study aims to identify the Type 2 Diabetes patients who are at risk of developing diabetic Kidney Disease 
(DKD). This study compares the performance of classification algorithms that are commonly used to 
identify patients at risk of developing DKD when predicting for short, medium and long terms. We used 
5,097 records at 36 clinics from 2005 to 2017. Syntactic minority oversampling and random undersampling 
were used to create a balanced dataset. Our findings show that the performance of classification algorithms 
depends on both the period and purpose of prediction, whether the prediction is to identify people who will 
not develop DKD or determine at-risk patients. Undersampling as opposed to oversampling improved 
performance. 19 predictors and their importance in short, medium and long terms were identified. This 
study provides guidelines for an automated system to prompt type-2 diabetes patients for screening, which 
offers a potential reduction of the burden placed upon the clinical settings. 
Keywords 
Predictive analytics, chronic disease, artificial neural networks, multi-task learning, regression 
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Extended Abstract 
One of the major complications of Type 2 Diabetes (T2D) is diabetic kidney disease (DKD). The T2D 
prevalence is increasing worldwide (World Health Organization, 2016) from 382 million in 2013 to 592 
million people in 2035 (Aguiree et al., 2013). Landray et al. (2010) have reported that 25-40% of patients 
with T2D develop chronic kidney disease. DKD is associated with the increased mortality among T2D 
patients (Afkarian et al., 2013). While out of five stages of DKD, the identification of patients at early stages 
of 1-3 is important for the treatment; typically signs and symptoms of DKD do not show up until later stages 
(Ware, 2018).  The rise in the number of T2D patients and the fact that T2D is the leading cause of chronic 
kidney disease (Subramanian and Hirsch, 2018) make it imperative to identify T2D patients at risk of DKD 
early. This enables targeted disease management in order to prevent the progression of DKD.  
There are two approaches for preventing DKD progression among T2D patients. In the first approach, every 
T2D patient is targeted by public health policies, which is highly costly (Jain and Mottl, 2015). In the second 
approach, a subpopulation of T2D patients is predicted as “at-risk” using machine learning classification 
algorithms.  Machine learning techniques have the potential to recognize the complex patterns in electronic 
medical records (EMR) and identify patients at risk of developing diseases (Capan et al., 2017; Ferroni et 
al., 2017; Lagani et al., 2013; Uyar et al., 2015) such as DKD. Advances in the field of machine learning allow 
for better predictions of target groups with the risk of DKD progression (Low et al., 2017). Prediction of 
DKD offers the promise of prioritizing diagnostic and therapeutic processes in the context of overwhelming 
patient demand.  On an individual patient care basis, physicians are well-equipped to identify those at risk 
of DKD.  However, when attempting to issue proactive, appropriate notification to patients to schedule an 
appointment for laboratory screening across a patient panel of thousands, the choice of good classification 
algorithm is an important challenge; that is the topic of this article. 
The current study aims to answer the following research questions (RQ):  
RQ1: Is there any difference in performance of classification algorithms to identify patients at risk of DKD 
progression when predicting for short, medium, or long-term and using random sampling, SMOTE, or 
RUS?  
RQ2: What are the predictors of DKD? Does the importance of each predictor change when predicting for 
short, medium, or long term?  
 
Figure 1. Methodology 
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In order to answer to the above questions, the current study runs the classification algorithms used in 
previous literature (Leung et al., 2013); namely partial least square regression (PLSR), classification and 
regression tree (C&RT), C5.0 decision tree (C 5.0 DT), random forest (RF), naïve Bayes (NB), neural 
network (NN) and support vector machine (SVM) for the linked daily generated EMRs collected from 36 
general practice offices. The resampling techniques were no resampling, SMOTE, and RUS. In addition, the 
analysis was conducted for 1 year, 3 years and 8 years of prediction. Our findings show that the performance 
of predictive techniques to predict DKD depends on 1) the period of prediction being short, medium, or 
long-term and 2) whether the purpose of prediction is to identify T2D patients at risk of developing DKD 
or those that are not at risk. Figure 1 presents the methodology used in this study. 
Our findings show that both discrimination and calibration performances of predictive technique are not 
only related to the period of prediction (short, medium, and long-term), but also depends on the purpose 
of prediction, whether the prediction is an attempt to identify T2D people who will not develop DKD or 
identify T2D patients at risk of developing DKD. For instance, in the short term, NN-RUS shows better 
performance as measured by AUC and MCC and MCE particularly when the prediction is looking for T2D 
patients who are going to develop DKD, measured by sensitivity. However, the results show that C 5.0 DT-
RUS better predicts T2D patients who are not at risk of DKD, since its specificity is higher than other 
predictive methods. When predicting for the medium and long terms, the choice of technique, we can 
similarly observe that RF-RUS has the best performance, unless the objective is to identify T2D patients 
who are not at risk of developing DKD. Although in 8-year prediction RF-SMOTE showed better MCE 
compared to RF-RUS, the difference was not statistically significant and as such, it can be treated similarly 
to RF-RUS. We have incorporated these results in full paper.  
This is the first time in literature that the change of predictors’ importance for developing DKD among T2D 
patients has been examined through different predicting periods (1, 3, and 8-year predictions). 
 
